Matthew Mefford to Comorbidity
This is a "connection" page, showing publications Matthew Mefford has written about Comorbidity.
Connection Strength
0.080
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.040
-
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults: REGARDS Study. Circ Cardiovasc Qual Outcomes. 2020 12; 13(12):e006683.
Score: 0.040